A Texas A&M epidemiologist says the new variant carries concerning mutations, but when it comes to infectiousness and severity, only time will tell.
More people will likely be gathering this year, but some will still be weighing pandemic-related concerns.
Results from a Texas A&M School of Public Health study show the spread of infectious diseases can be prevented and monitored during sporting competitions.
The drug developed by Texas A&M and University of Texas MD Anderson Cancer Center scientists could be an effective treatment for COVID-19 and other illnesses.
A Texas A&M study identified various factors that played a role in the resumption of risky travel and leisure behaviors during the pandemic.
The new research findings, although preliminary, raise concerns about the potential long-term effects of COVID-19, a Texas A&M cognitive neuroscientist says.
Texas A&M researcher Timothy H. Callaghan and colleagues propose five short-term steps to prioritize health over politics.
Texas A&M offers both shots for free to students, faculty and staff.
An increasing number of people are taking the drug commonly used to treat parasites in animals. Veterinary and infectious disease expert Dr. Gerald Parker says vaccines remain a safe and effective way to protect against the virus.
A Texas A&M expert explains what's next for the COVID-19 crisis, from FDA approvals and booster shots to the fight against new variants.